Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidant

被引：37

作者：

Choudhary R. ^{[1
]}

Mishra K.P. ^{[2
]}

Subramanyam C. ^{[1
]}

机构：

[1] Department of Biochemistry, Osmania University

[2] Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre

来源：

Indian Journal of Clinical Biochemistry | 2006年 / 21卷 / 2期

关键词：

Antioxidants; Calcineurin activity; Cardiac hypertrophy; Eugenol; Isoproterenol; ROS;

D O I：

10.1007/BF02912923

中图分类号：

学科分类号：

摘要：

Recent reports on the involvement of calcineurin in cardiac hypertrophy and its susceptibility to free radicals, prompted us to examine possible beneficial effects of dietary antioxidants in this regard. In continuation of initial in vitro studies revealing eugenol to be a potent calcineurin inhibitor, we investigated its ability to reverse isoproterenol-induced cardiac hypertrophy in rats. Intraperitoneal administration of isoproterenol (1 mg/kg body wt/day for 10 days) induced cardiac hypertrophy with increased heart weight and enhanced apoptosis of myocytes concomitant with accumulation of reactive oxygen species, decreased glutathione contents, increased activities of calcineurin and protein kinase C in ventricular tissue. Administering eugenol for 3 days (1 mg/kg body wt/ twice a day), followed by combined administration of isoproterenol and eugenol resulted in significant reversal of cardiac hypertrophy and restoration of above changes. These results suggest that eugenol, a natural antioxidant of dietary origin, may offer potential benefits in the management of cardiac hypertrophy.

引用

页码：107 / 113

页数：6

共 29 条

[1]

Braun M., Simonis G., Birkner K., Pauke B., Strasser R.H., Regulation of protein kinase C isozyme and calcineurin expression in isoproterenol induced cardiac hypertrophy, J. Cardiovasc. Pharmacol., 41, pp. 946-954, (2003)

[2]

Cao Z., Tsang M., Zhao H., Li Y., Induction of endogenous antioxidants and phase 2 enzymes by a-lipoic acid in rat cardiac H9C2 cells: Protection against oxidative injury, Biochem. Biophys. Res. Commun., 310, pp. 979-985, (2003)

[3]

Chattopadhyay A., Biswas S., Bandyopadhyay D., Sarkar C., Datta A.G., Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine, Mol. Cell. Biochem., 245, pp. 43-49, (2003)

[4]

Evaluation of Certain Food Additives and Contaminants, (1982)

[5]

Hissin P.J., Hilf R., A fluorimetric method for determination of oxidized and reduced glutathione in tissues, Anal. Biochem., 74, pp. 214-226, (1976)

[6]

Huang Y.C., Wu B.N., Lin Y.T., Chen S.J., Chiu C.C., Cheng C.J., Chen I.J., Eugenodilol: A third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities, J. Cardiovasc. Pharmacol., 34, pp. 10-20, (1999)

[7]

Jayashree T., Subramanyam C., Antiaflatoxigenic activity of eugenol is due to inhibition of lipid peroxidation, Lett. Appl. Microbiol., 28, pp. 179-183, (1999)

[8]

Kang Y.J., Zhou Z.X., Wu H., Wang G.W., Saari J.T., Klein J.B., Metallothionein inhibits myocardial apoptosis in copper-deficient mice: Role of atrial natriuretic peptide, Lab. Invest., 80, pp. 745-757, (2000)

[9]

Leinwand L.A., Calcineurin inhibition and cardiac hypertrophy: A matter of balance, Proc. Natl. Acad. Sci. USA, 98, pp. 2947-2949, (2001)

[10]

Lin Y.T., Wu B.N., Horng C.F., Huang Y.C., Hong S.J., Lo Y.C., Cheng C.J., Chen I.J., Isoeugenolol: A selective beta 1-drenergic antagonist with tracheal and vascular smooth muscle relaxant properties, Jpn. J. Pharmacol., 80, pp. 127-136, (1999)

← 1 2 3 →